Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli
- PMID: 2117612
Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli
Abstract
The kringle-2 domain (residues 176-262) of tissue-type plasminogen activator (t-PA) was cloned and expressed in Escherichia coli. The recombinant peptide, which concentrated in cytoplasmic inclusion bodies, was isolated, solubilized, chemically refolded, and purified by affinity chromatography on lysine-Sepharose to apparent homogeneity. [35S]Cysteine-methionine-labeled polypeptide was used to study the interactions of kringle-2 with lysine, fibrin, and plasminogen activator inhibitor-1. The kringle-2 domain bound to lysine-Sepharose and to preformed fibrin with a Kd = 104 +/- 6.2 microM (0.86 +/- 0.012 binding site) and a Kd = 4.2 +/- 1.05 microM (0.80 +/- 0.081 binding site), respectively. Competition experiments and direct binding studies showed that the kringle-2 domain is required for the formation of the ternary t-PA-plasminogen-intact fibrin complex and that the association between the t-PA kringle-2 domain and fibrin does not require plasmin degradation of fibrin and exposure of new COOH-terminal lysine residues. We also observed that kringle-2 forms a complex with highly purified guanidine-activated plasminogen activator inhibitor-1, dissociable by 0.2 M epsilon-aminocaproic acid. The kringle-2 polypeptide significantly inhibited tissue plasminogen activator/plasminogen activator inhibitor-1 interaction. The kringle-2 domain bound to plasminogen activator inhibitor-1 in a specific and saturable manner with a Kd = 0.51 +/- 0.055 microM (0.35 +/- 0.026 binding site). Therefore, the t-PA kringle-2 domain is important for the interaction of t-PA not only with fibrin, but also with plasminogen activator inhibitor-1 and thus represents a key structure in the regulation of fibrinolysis.
Similar articles
-
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295. Protein Eng. 1995. PMID: 8869642
-
On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.J Biol Chem. 1986 Oct 25;261(30):14214-8. J Biol Chem. 1986. PMID: 3021732
-
Purification and characterization of tissue plasminogen activator kringle-2 domain expressed in Escherichia coli.Biochemistry. 1989 Feb 21;28(4):1884-91. doi: 10.1021/bi00430a068. Biochemistry. 1989. PMID: 2497771
-
Structure and function of human tissue-type plasminogen activator (t-PA).J Cell Biochem. 1986;32(3):169-78. doi: 10.1002/jcb.240320302. J Cell Biochem. 1986. PMID: 3097031 Review.
-
Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.Biol Chem. 2002 Jan;383(1):93-9. doi: 10.1515/BC.2002.009. Biol Chem. 2002. PMID: 11928826 Review.
Cited by
-
Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli.BMC Biotechnol. 2015 Mar 1;15:13. doi: 10.1186/s12896-015-0127-y. BMC Biotechnol. 2015. PMID: 25886739 Free PMC article.
-
Structural elements in glycoprotein 70 from polytropic Friend mink cell focus-inducing virus and glycoprotein 71 from ecotropic Friend murine leukemia virus, as defined by disulfide-bonding pattern and limited proteolysis.J Virol. 1994 Aug;68(8):5133-41. doi: 10.1128/JVI.68.8.5133-5141.1994. J Virol. 1994. PMID: 8035513 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources